Skip to main content
. 2016 Jul 6;263(10):1946–1953. doi: 10.1007/s00415-016-8218-9

Table 1.

Survey on the comorbidities of individuals with no visual height intolerance, pure visual height intolerance, and acrophobia

Non-vHI (n = 702) Pure vHI (n = 445) Acrophobia (n = 129) Sum Pure vHI + acrophobia vs non-vHI Pure vHI vs acrophobia
Chi-square df p Chi-square df p
Any anxiety condition 178 166 64 408 31.431 1 <0.001 6.310 1 0.012
Major depression 109 135 48 292 47.862 1 <0.001 2.221 1 0.136
Chronic fatigue 69 47 19 135 .839 1 0.360 1.765 1 0.184
Panic attacks 65 75 47 187 35.749 1 <0.001 22.005 1 <0.001
Agoraphobia 14 15 12 41 7.473 1 0.006 7.591 1 0.006
Social phobia 27 35 15 77 13.217 1 <0.001 1.639 1 0.200
Generalized anxiety 42 46 18 106 11.110 1 0.001 1.185 1 0.276
Specific phobic fears 32 49 25 106 27.917 1 <0.001 5.943 1 0.015
Obsession/compulsion 12 24 11 47 17.173 1 <0.001 1.598 1 0.206
Hypochondria 7 18 4 29 11.423 1 0.001 0.272 1 0.602
Posttraumatic stress 32 42 22 96 19.777 1 <0.001 5.546 1 0.019
Migraine 180 109 56 345 1.366 1 0.242 17.215 1 <0.001
Motion sickness 165 122 35 322 2.364 1 0.124 0.008 1 0.927
Menière’s disease 8 9 5 22 3.059 1 0.080 1.403 1 0.236
Other vertiginous diseases 73 28 11 112 5.325 1 0.021 0.818 1 0.366
Traumatic trigger of vHI 49 26 75 7.615 1 0.006

Bold represents that statistical significance set at the conventional two-tailed 5 % level